Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells
Authors
Keywords
-
Journal
STEM CELLS
Volume 34, Issue 3, Pages 781-790
Publisher
Wiley
Online
2016-01-06
DOI
10.1002/stem.2280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone Marrow-Derived Mesenchymal Stromal Cells Harness Purinergenic Signaling to Tolerize Human Th1 Cells In Vivo
- (2015) Shoba Amarnath et al. STEM CELLS
- Human CD4+CD39+regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+exosomes or CD73+cells
- (2014) P. J. Schuler et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Adenosine production by human B cells and B cell-mediated suppression of activated T cells
- (2013) Z. Saze et al. BLOOD
- CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes
- (2013) Alessia Parodi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD73 expression on extracellular vesicles derived from CD4+CD25+Foxp3+T cells contributes to their regulatory function
- (2013) Lesley Ann Smyth et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD39 is involved in mediating suppression byMycobacterium bovisBCG-activated human CD8+CD39+regulatory T cells
- (2013) Mardi C. Boer et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice
- (2013) Long Wang et al. PLoS One
- CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function
- (2013) Jong Joo Lee et al. Purinergic Signalling
- Mesenchymal Stem Cells Secrete Immunologically Active Exosomes
- (2013) Bin Zhang et al. STEM CELLS AND DEVELOPMENT
- Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease
- (2012) H. Tsukamoto et al. BLOOD
- Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling
- (2012) Aram Mokarizadeh et al. IMMUNOLOGY LETTERS
- CD73: a potent suppressor of antitumor immune responses
- (2012) Paul. A. Beavis et al. TRENDS IN IMMUNOLOGY
- Inhibition of T-Cell Proliferation by Murine Multipotent Mesenchymal Stromal Cells is Mediated by CD39 Expression and Adenosine Generation
- (2011) Christine Sattler et al. CELL TRANSPLANTATION
- Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
- (2011) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- Adenosine Generation and Signaling during Acute Kidney Injury
- (2011) J. D. Bauerle et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mesenchymal stromal cell ‘licensing’: a multistep process
- (2011) M Krampera LEUKEMIA
- Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation
- (2011) Darwin J Prockop et al. MOLECULAR THERAPY
- Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation
- (2011) Moïra François et al. MOLECULAR THERAPY
- Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes
- (2011) Felipe Saldanha-Araujo et al. Stem Cell Research
- High Expression of the Ectonucleotidase CD39 on T Cells from the Inflamed Site Identifies Two Distinct Populations, One Regulatory and One Memory T Cell Population
- (2010) H. Moncrieffe et al. JOURNAL OF IMMUNOLOGY
- Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+Regulatory T Cells
- (2009) Magis Mandapathil et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now